The Claim
Dietary intervention-induced weight loss in obese adults over 12 months improves cardiometabolic biomarkers including insulin, HOMA-IR, CRP, and adiponectin, without altering DunedinPACE epigenetic aging.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When obese adults lose weight through diet over 12 months, their insulin, HOMA-IR, CRP, and adiponectin levels improve, but their DunedinPACE epigenetic aging score does not change.
See the scientific wording
Weight loss through dietary intervention improves cardiometabolic biomarkers—including insulin, HOMA-IR, CRP, and adiponectin—in obese adults over 12 months, but these improvements occur independently of changes in DunedinPACE epigenetic aging, indicating that metabolic health can improve without measurable shifts in this biomarker.
When fat tissue shrinks, it releases fewer signals that cause insulin resistance and inflammation, which lowers blood sugar and inflammation markers. This happens even if the biological aging clock measured by DNA changes does not move.
What the research says
1 studyWhen obese people lose weight by eating better, their blood sugar and inflammation get better — but their 'biological age' clock (DunedinPACE) doesn’t necessarily change. So, you can get healthier without seeing a shift in this particular aging marker.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.